In vitro activity of BAL30072 against Burkholderia pseudomallei

International Journal of Antimicrobial Agents

Volumn 38, Issue 2, 2011, Pages 157-159

  Mima, Takehiko ^a,c   Kvitko, Brian H ^a   Rholl, Drew A ^a   Page, Malcolm G P ^b   Desarbre, Eric ^b   Schweizer, Herbert P ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b BASILEA PHARMACEUTICA INTERNATIONAL LTD   (Switzerland)

^c KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Burkholderia pseudomallei; Efflux; Melioidosis; Monosulfactam; Siderophore; Therapy

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BACTERIAL PROTEIN; BAL 30072; BETA LACTAMASE; BETA LACTAMASE PENA; CARBENICILLIN; CEFTAZIDIME; IMIPENEM; MALLEOBACTIN; MEROPENEM; PYOCHELIN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; BACTERIUM MUTANT; BURKHOLDERIA PSEUDOMALLEI; CONTROLLED STUDY; DRUG EFFICACY; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; THAILAND;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BIOLOGICAL TRANSPORT; BURKHOLDERIA PSEUDOMALLEI; ENVIRONMENTAL MICROBIOLOGY; HUMANS; MELIOIDOSIS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MONOBACTAMS; THAILAND; THIAZOLES; TIME FACTORS;

EID: 79959735594     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2011.03.019     Document Type: Article

References (15)

1. W.J. Wiersinga, T. van der Poll, N.J. White, N.P. Day, and S.J. Peacock Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei Nat Rev Microbiol 4 2006 272 282
2. D.A.B. Dance Melioidosis glanders as possible biological weapons W. Fong, K. Alibek, Bioterrorism and infectious agents: a new dilemma for the 21st century 2005 Springer Science and Business Media New York, NY 99 145
3. A.C. Cheng, and B.J. Currie Melioidosis: epidemiology, pathophysiology, and management Clin Microbiol Rev 18 2005 383 416 (Pubitemid 40548298)
4. V. Wuthiekanun, and S.J. Peacock Management of melioidosis Expert Rev Anti Infect Ther 4 2006 445 455 (Pubitemid 43905466)
5. M.G.P. Page, C. Dantier, and E. Desarbre In vitro properties of BAL30072, a novel siderophore sulfactam with activity against multiresistant Gram-negative bacilli Antimicrob Agents Chemother 54 2010 2291 2302
6. S. Mushtaq, M. Warner, and D. Livermore Activity of the siderophore monobactam BAL30072 against multiresistant non-fermenters J Antimicrob Chemother 65 2010 266 270
7. D. DeShazer, P. Brett, R. Carlyon, and D. Woods Mutagenesis of Burkholderia pseudomallei with Tn5-OT182: isolation of motility mutants and molecular characterization of the flagellin structural gene J Bacteriol 179 1997 2116 2125 (Pubitemid 27146863)
8. L.A. Trunck, K.L. Propst, V. Wuthiekanun, A. Tuanyok, S.M. Beckstrom-Sternberg, and J.S. Beckstrom-Sternberg Molecular basis of rare aminoglycoside susceptibility and pathogenesis of Burkholderia pseudomallei clinical isolates from Thailand PLoS Negl Trop Dis 3 2009 e519
9. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 7th ed. Document M7-A7. Wayne, PA: CLSI; 2006.
10. A.J. Godfrey, S. Wong, D.A. Dance, W. Chaowagul, and L.E. Bryan Pseudomonas pseudomallei resistance to β-lactam antibiotics due to alterations in the chromosomally encoded β-lactamase Antimicrob Agents Chemother 35 1991 1635 1640
11. C. Tribuddharat, R.A. Moore, P. Baker, and D.E. Woods Burkholderia pseudomallei class A β-lactamase mutations that confer selective resistance against ceftazidime or clavulanic acid inhibition Antimicrob Agents Chemother 47 2003 2082 2087 (Pubitemid 36753554)
12. R.A. Moore, D. DeShazer, S. Reckseidler, A. Weissman, and D.E. Woods Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei Antimicrob Agents Chemother 43 1999 465 470 (Pubitemid 29109504)
13. T. Mima, and H.P. Schweizer The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system Antimicrob Agents Chemother 54 2010 3113 3120
14. A.F. Alice, C.S. Lopez, C.A. Lowe, M.A. Ledesma, and J.H. Crosa Genetic and transcriptional analysis of the siderophore malleobactin biosynthesis and transport genes in the human pathogen Burkholderia pseudomallei K96243 J Bacteriol 188 2006 1551 1566 (Pubitemid 43228689)
15. C.D. Cox, K.L. Rinehart, M.L. Moore, and J. Carter Cook Pyochelin: novel structure of an iron-chelating growth promoter for Pseudomonas aeruginosa Proc Natl Acad Sci USA 78 1981 4256 4260